45 Results for "

GPC3

" in MedChemExpress (MCE) Product Catalog:
Products (45)

45 Results for "GPC3" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
1
1 Cited Publications
Cat. No.: HY-P99013
CAS No.: 1365267-33-9
Synonyms: GC33; RO5137382

Target:  

Glycoprotein VI

Research Areas:  

Cancer

Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth [3] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70487
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Glypican-3; GTR2-2; Intestinal protein OCI-5; MXR7; GPC3; OCI5
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-153360
CAS No.: 2873460-70-7
Purity:  98.99%
Research Areas:  

Cancer

MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells .
loading...
    loading...
Cat. No.: HY-W1124925
CAS No.: 3066439-94-6
DOTA-GPC3 targeting peptide 2 (Sequence 30) is a RDC peptide targeting GPC3, with Kd of 0.3 nM. DOTA-GPC3 targeting peptide 2 is composed of DOTA and GPC3 targeting peptide 2. DOTA-GPC3 targeting peptide 2 can be labeled with radioactive elements .
loading...
    loading...
Cat. No.: HY-P10888A
Target:  

Glycoprotein VI

Research Areas:  

Cancer

GPC3 targeting peptide 1 TFA is a GPC3 targeting peptide, with a Kd value of 0.23 nM .
loading...
    loading...
Cat. No.: HY-P990841

Target:  

Glycoprotein VI

Research Areas:  

Cancer

Anti-pan-Glypican Antibody (HS20) is a kind of human IgG1 κ human antibody, targeting to human pan-Glypican. Anti-pan-Glypican Antibody (HS20) can neutralize the heparan sulfate (HS) chains on GPC3 thereby disrupting the Wnt3a-GPC3 interactions leading to blockade of the Wnt3a/β-catenin signaling. Anti-pan-Glypican Antibody (HS20) can be used for the research of cancer, such as hepatocellular carcinoma (HCC) .
loading...
    loading...
Cat. No.: HY-P10888
CAS No.: 3066113-41-2
Target:  

Glycoprotein VI

Research Areas:  

Cancer

GPC3 targeting peptide 1 is a GPC3 targeting peptide, with a Kd value of 0.23 nM .
loading...
    loading...
Cat. No.: HY-P990840

Target:  

Glycoprotein VI

Research Areas:  

Cancer

Anti-GPC3 Antibody (YP7) is a kind of mouse IgG1 κ chimeric antibody, targeting to human GPC3. Anti-GPC3 Antibody (YP7) reacts with the C-lobe of cell surface-associated glypican-3 (GPC3). Anti-GPC3 Antibody (YP7) can be used for the research of cancer, such as hepatocellular carcinoma (HCC) .
loading...
    loading...
Cat. No.: HY-RS05628
Research Areas:  

Others

GPC3 Human Pre-designed siRNA Set A contains three designed siRNAs for GPC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16630
Research Areas:  

Others

Gpc3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gpc3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P991448

Target:  

Glycoprotein VI

Research Areas:  

Cancer

MDX-1414 is a human IgG1 monoclonal antibody (mAb) targeting GPC3. MDX-1414 has antitumor activity in the HepG2 xenograft model. MDX-1414 can be used in liver cancer research. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Cat. No.: HY-RS23065
Research Areas:  

Others

Gpc3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Gpc3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P11618
Target:  

Glycoprotein VI

Research Areas:  

Cancer

10P3Me is a Glypican-3 (GPC3)-targeting probe with a Ka of 93.8 nM for the human target. 10P3Me exhibits high binding affinity to GPC3, targets GPC3-positive cells, and serves as an agent for PET imaging. 10P3Me selectively accumulates in GPC3-positive tumor tissues, including subcutaneous xenograft models and orthotopic HepG2-LUC liver cancer models, to achieve precise localization of lesions .
loading...
    loading...
Cat. No.: HY-P992457

Research Areas:  

Cancer

SAR444200 is a nanobody targeting GPC3 (glypican-3) and TCRαβ (T-cell receptor αβ). The KD of SAR444200 for human GPC3 is 0.023 nM, and its KD for human TCRαβ is 5.2 nM. SAR444200 mediates T cell-dependent cytotoxicity, and exhibits high selectivity and killing activity against GPC3-positive tumor cells. SAR444200 binds to GPC3 in a dual-epitope manner, and binds to TCRαβ via its N-terminal nanobody, forming an artificial immunological synapse between T cells and tumor cells. SAR444200 can be used in studies of GPC3+ solid tumors, including liver cancer, lung squamous cell carcinoma and melanoma .
loading...
    loading...
Cat. No.: HY-182099
DSPE-PEG1000-DHLASLWWGTEL is a PEG compound which composed of DSPE and a GPC3 targeting peptide DHLASLWWGTEL. The DHLASLWWGTEL peptide partially and specifically binds to GPC3-positive cells, achieving precise targeting. DSPE-PEG1000-DHLASLWWGTEL can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-182099A
DSPE-PEG2000-DHLASLWWGTEL is a PEG compound which composed of DSPE and a GPC3 targeting peptide DHLASLWWGTEL. The DHLASLWWGTEL peptide partially and specifically binds to GPC3-positive cells, achieving precise targeting. DSPE-PEG2000-DHLASLWWGTEL can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-182099B
DSPE-PEG3400-DHLASLWWGTEL is a PEG compound which composed of DSPE and a GPC3 targeting peptide DHLASLWWGTEL. The DHLASLWWGTEL peptide partially and specifically binds to GPC3-positive cells, achieving precise targeting. DSPE-PEG3400-DHLASLWWGTEL can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-182099C
DSPE-PEG5000-DHLASLWWGTEL is a PEG compound which composed of DSPE and a GPC3 targeting peptide DHLASLWWGTEL. The DHLASLWWGTEL peptide partially and specifically binds to GPC3-positive cells, achieving precise targeting. DSPE-PEG5000-DHLASLWWGTEL can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-185742
Research Areas:  

Cancer

ZW-251 is a glypican-3 (GPC3)-targeted antibody-drug conjugate (ADC) with topoisomerase-I inhibitory activity. ZW-251 induces cytotoxicity, penetrates tumor spheroids, exerts bystander cytotoxicity, and inhibits tumor growth in hepatocellular carcinoma models. ZW-251 can be used for the research of hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-P992011

Target:  

Glycoprotein VI

Research Areas:  

Cancer

CAT-07 is an anti-human GPC3/Glypican 3 antibody. CAT-07 can be used for the research of cancer, such as hepatocellular carcinoma.
loading...
    loading...